{"id":7016,"date":"2023-11-14T15:25:00","date_gmt":"2023-11-14T14:25:00","guid":{"rendered":"https:\/\/nanexa.com\/mfn_news\/nanexa-presenterade-halsoekonomiska-data-pa-internationell-kongress\/"},"modified":"2023-11-14T15:25:00","modified_gmt":"2023-11-14T14:25:00","slug":"nanexa-presenterade-halsoekonomiska-data-pa-internationell-kongress","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-presenterade-halsoekonomiska-data-pa-internationell-kongress\/","title":{"rendered":"Nanexa presenterade h\u00e4lsoekonomiska data p\u00e5 internationell kongress"},"content":{"rendered":"
\n

Nanexa AB presenterade idag data fr\u00e5n en h\u00e4lsoekonomisk studie p\u00e5 den internationella h\u00e4lsoekonomiska kongressen ISPOR Europe 2023 i K\u00f6penhamn, Danmark. Presentationen hade utsetts till en muntlig podium-presentation som h\u00f6lls av Nanexas Medical Director, Bengt Gustavsson, och har titeln "Association between Adherence to Lenalidomide and Patient-Reported Outcomes in Patients with Multiple Myeloma: A Systematic Literature Review".<\/strong><\/p>\n<\/div>\n

\n

F\u00f6rfattare till abstractet \u00e4r Karthik Ramasamy, Marie von Lilienfeld-Toal, Christopher Maisel, Bengt Gustavsson, Kristine B\u00e4ck, Axel Glasmacher och Xavier Leleu.<\/p>\n

"Nu \u00e4r det tydligt f\u00f6r alla att vi har tagit ett f\u00f6rsta steg mot byggandet av en h\u00e4lsoekonomisk fil f\u00f6r NEX-20 vid behandling av multipelt myelom", s\u00e4ger Nanexas VD David Westberg. "En s\u00e5 kallad "Systematic Literature Review" utg\u00f6r ett av de f\u00f6rsta stegen i den avancerade processen att bygga en h\u00e4lsoekonomisk bas f\u00f6r den prisans\u00f6kan man m\u00e5ste g\u00e5 in med till ber\u00f6rda myndigheter den dagen man f\u00e5r ett regulatoriskt godk\u00e4nnande av det nya l\u00e4kemedlet. I korta drag visar v\u00e5r studie att patienters f\u00f6ljsamhet till sin l\u00e4kemedelsbehandling mot multipelt myelom kan vara suboptimal. Dock beh\u00f6vs mer forskning p\u00e5 omr\u00e5det eftersom de studier som hittills gjorts ofta visar stora variationer n\u00e4r man j\u00e4mf\u00f6r dem med varandra."<\/p>\n<\/div>\n

\n

F\u00f6r mer information kontakta:<\/strong><\/p>\n

\n

David Westberg \u2013 VD, Nanexa AB (publ)\u00a0
Telefon: 0709-42 83 03
E-post:\u00a0david.westberg@nanexa.se<\/a>
www.nanexa.com<\/a><\/p>\n

Erik Penser Bank \u00e4r bolagets Certified Adviser och n\u00e5s p\u00e5 08-463 83 00, e-post: certifiedadviser@penser.se<\/p>\n<\/div>\n

\n

Om Nanexa AB (publ)<\/strong><\/p>\n

\n

Nanexa \u00e4r ett l\u00e4kemedelsbolag som utvecklar injicerbara l\u00e4kemedel baserade p\u00e5 det patenterade och innovativa drug delivery-systemet PharmaShell\u00ae \u2013 ett system som m\u00f6jligg\u00f6r n\u00e4sta generations l\u00e5ngverkande injicerbara l\u00e4kemedel med h\u00f6g drug load, tillverkade med atomlagerprecision. Nanexa utvecklar egna produkter och har dessutom samarbetsavtal med flera l\u00e4kemedelsbolag, d\u00e4ribland Novo Nordisk och AstraZeneca.<\/p>\n

Nanexas aktie \u00e4r noterad p\u00e5 Nasdaq First North Growth Market i Stockholm (NANEXA).<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

Nanexa presenterade h\u00e4lsoekonomiska data p\u00e5 internationell kongress<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Nanexa AB presenterade idag data fr\u00e5n en h\u00e4lsoekonomisk studie p\u00e5 den internationella h\u00e4lsoekonomiska kongressen ISPOR Europe 2023 i K\u00f6penhamn, Danmark. Presentationen hade utsetts till en muntlig podium-presentation som h\u00f6lls av Nanexas Medical Director, Bengt Gustavsson, och har titeln ”Association between Adherence to Lenalidomide and Patient-Reported Outcomes in Patients with Multiple Myeloma: A Systematic Literature Review”.<\/p>\n","protected":false},"template":"","class_list":["post-7016","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nNanexa presenterade h\u00e4lsoekonomiska data p\u00e5 internationell kongress - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/nanexa-presenterade-halsoekonomiska-data-pa-internationell-kongress\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa presenterade h\u00e4lsoekonomiska data p\u00e5 internationell kongress - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nanexa AB presenterade idag data fr\u00e5n en h\u00e4lsoekonomisk studie p\u00e5 den internationella h\u00e4lsoekonomiska kongressen ISPOR Europe 2023 i K\u00f6penhamn, Danmark. Presentationen hade utsetts till en muntlig podium-presentation som h\u00f6lls av Nanexas Medical Director, Bengt Gustavsson, och har titeln "Association between Adherence to Lenalidomide and Patient-Reported Outcomes in Patients with Multiple Myeloma: A Systematic Literature Review".\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/nanexa-presenterade-halsoekonomiska-data-pa-internationell-kongress\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-presenterade-halsoekonomiska-data-pa-internationell-kongress\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-presenterade-halsoekonomiska-data-pa-internationell-kongress\\\/\",\"name\":\"Nanexa presenterade h\u00e4lsoekonomiska data p\u00e5 internationell kongress - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2023-11-14T14:25:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-presenterade-halsoekonomiska-data-pa-internationell-kongress\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-presenterade-halsoekonomiska-data-pa-internationell-kongress\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-presenterade-halsoekonomiska-data-pa-internationell-kongress\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanexa presenterade h\u00e4lsoekonomiska data p\u00e5 internationell kongress\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa presenterade h\u00e4lsoekonomiska data p\u00e5 internationell kongress - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/nanexa-presenterade-halsoekonomiska-data-pa-internationell-kongress\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa presenterade h\u00e4lsoekonomiska data p\u00e5 internationell kongress - Nanexa AB","og_description":"Nanexa AB presenterade idag data fr\u00e5n en h\u00e4lsoekonomisk studie p\u00e5 den internationella h\u00e4lsoekonomiska kongressen ISPOR Europe 2023 i K\u00f6penhamn, Danmark. Presentationen hade utsetts till en muntlig podium-presentation som h\u00f6lls av Nanexas Medical Director, Bengt Gustavsson, och har titeln \"Association between Adherence to Lenalidomide and Patient-Reported Outcomes in Patients with Multiple Myeloma: A Systematic Literature Review\".","og_url":"https:\/\/nanexa.com\/mfn_news\/nanexa-presenterade-halsoekonomiska-data-pa-internationell-kongress\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-presenterade-halsoekonomiska-data-pa-internationell-kongress\/","url":"https:\/\/nanexa.com\/mfn_news\/nanexa-presenterade-halsoekonomiska-data-pa-internationell-kongress\/","name":"Nanexa presenterade h\u00e4lsoekonomiska data p\u00e5 internationell kongress - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2023-11-14T14:25:00+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-presenterade-halsoekonomiska-data-pa-internationell-kongress\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/nanexa-presenterade-halsoekonomiska-data-pa-internationell-kongress\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-presenterade-halsoekonomiska-data-pa-internationell-kongress\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nanexa presenterade h\u00e4lsoekonomiska data p\u00e5 internationell kongress"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/7016","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=7016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}